The Pennant Group, Inc. (PNTG) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $1.33B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Brent J. Guerisoli |
| IPO Date | 2019-10-01 | CAGR | 17.78% |
| Employees | 9,700 | Website | www.pennantgroup.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $1.74B | P/E | 28.98 | Forward P/E | 24.1 | PEG | 1.7 |
| P/S | 1.17 | P/B | 3.58 | P/CF | 25.94 | P/FCF | 57.24 |
| Sales | $1.10B | Sales 1Y | 37.9% | Sales 3Y | 119.57% | Sales 5Y | 160.84% |
| EPS | $1.32 | EPS 1Y | 15.38% | EPS 3Y | 107.37% | EPS 5Y | 125% |
| Sales QoQ | 4.42% | EPS QoQ | 4.17% | Sales QoQ Avg | 8.43% | EPS QoQ Avg | 7.59% |
| Gross Margin | 14.79% | Operating Margin | 5.77% | Profit Margin | 2.93% | ROCE | 7.18% |
| ROA | 3% | ROE | 10% | Altman Z Score | 2.67 | Piotroski Score | 6 |
| Current Ratio | 1.2 | Quick Ratio | 1.2 | Cash Ratio | 0.1 | Op. CF Ratio | 0.12 |
| Debt/Equity | 1.38 | Debt/Assets | 0.48 | Lt Debt/Equity | 1.27 | Lt Debt/Cap. | 0.35 |
| Intrst Cov. | 13.97 | Inventory Turnover | — | Asset Turnover | 1.06 | Receivables Turnover | 8.27 |
| Enterprise Value | $1.74B | P/E Ratio | 28.98 |
| Forward P/E | 24.1 | PEG Ratio | 1.7 |
| P/S Ratio | 1.17 | P/B Ratio | 3.58 |
| P/CF Ratio | 25.94 | P/FCF Ratio | 57.24 |
| EPS | $1.32 | EPS Growth 1Y | 15.38% |
| EPS Growth 3Y | 107.37% | EPS Growth 5Y | 125% |
| Revenue Growth 1Y | 37.9% | Gross Margin | 0.15% |
| Operating Margin | 0.06% | Profit Margin | 0.03% |
| ROE | 0.1% | ROA | 0.03% |
| ROCE | 0.07% | Current Ratio | 1.2 |
| Quick Ratio | 1.2 | Cash Ratio | 0.1 |
| Debt/Equity | 1.38 | Interest Coverage | 13.97 |
| Altman Z Score | 2.67 | Piotroski Score | 6 |
The Pennant Group, Inc. (PNTG) valuation & financials
The Pennant Group, Inc. (PNTG) has a market capitalization of $1.33B and trades at a price-to-earnings ratio of 29.0. It operates in the Healthcare sector (Medical - Care Facilities).
The Pennant Group, Inc.'s revenue grew +37.9% over the last year.
The Pennant Group, Inc.'s next earnings report is scheduled for November 4, 2026 after market close; analysts estimate EPS of $0.33. Check the earnings calendar to see all companies reporting this week.
The Pennant Group, Inc. (PNTG) — frequently asked questions
When does The Pennant Group, Inc. (PNTG) report earnings next?
The Pennant Group, Inc. is expected to report earnings on November 4, 2026 after market close. Analysts estimate EPS of $0.33.
What is The Pennant Group, Inc.'s market cap?
The Pennant Group, Inc. (PNTG) has a market capitalization of $1.33B.
What is PNTG's P/E ratio?
The Pennant Group, Inc. trades at a price-to-earnings ratio of 29.0, with trailing twelve-month EPS of $1.32.
How fast is The Pennant Group, Inc. growing?
The Pennant Group, Inc.'s revenue grew +37.9% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)